EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Cell surface GRP78 and the UPR pathway as novel promising therapeutic targets in cancer: an insight into the treatment of acute leukemia by using GRP78-CART cells

Nadia Giovanna Román-Anguiano, Paola Andrea Gutiérrez-Muñoz, Tania Angeles-Floriano, Nancy Lucero Martínez-Rodríguez, Laila Gutiérrez-Kobeh, Maria C Jimenez-Martinez, Ricardo Valle-Rios

Clinical and Translational Oncology · 2026

DOI: 10.1007/s12094-026-04413-6 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Translational Oncology, 2026. Verfasst von Nadia Giovanna Román-Anguiano und 6 weiteren Autor:innen. Beteiligte Einrichtung: Unidad Universitaria de Investigación, División de Investigación, Facultad de Medicina de la Universidad Nacional Autónoma de México, 04510, Mexico C…. Hauptthemen laut MEDLINE: Unfolded Protein Response, Heat-Shock Proteins. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Secretaría de Ciencia, Humanidades, Tecnología e Innovación-Secihti, Secretaría de Salud Mexico, Hospital Infantil de México Federico Gómez.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Around 70s decade, the discovery of endoplasmic reticulum (ER) chaperones as central regulators of protein folding and quality control set a new paradigm for the understanding of cellular homeostasis. With the arrival of global proteomic approaches, several ER chaperones, including the 78-kDa glucose-regulated protein (GRP78), were unexpectedly found at the cell surface of cancer cells, linking activation of the unfolded protein response (UPR) to tumor biology. Current knowledge suggests that cell surface GRP78 (csGRP78) is a promising therapeutic biomarker, as it is virtually absent on normal cells but enriched on multiple cancers, particularly leukemias. This review summarizes the roles of the three main UPR regulators-IRE1, ATF6, and PERK-and their crosstalk with csGRP78 in leukemia, emphasizing how this network can promote survival or apoptosis. Finally, recent preclinical studies using GRP78-directed CAR-T cells are discussed, highlighting csGRP78 and the UPR pathway as attractive targets for leukemia immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Unfolded Protein ResponseHeat-Shock ProteinsEndoplasmic Reticulum Chaperone BiPHumansActivating Transcription Factor 6Signal TransductionAnimalsProtein Serine-Threonine KinasesEndoribonucleaseseIF-2 Kinase

Stichwörter der Autor:innen

Acute lymphoblastic leukemiaCART cellsGRP78

Substanzen

Endoplasmic Reticulum Chaperone BiPHSPA5 protein, humanHeat-Shock ProteinsActivating Transcription Factor 6Protein Serine-Threonine KinasesATF6 protein, humanERN1 protein, humanEndoribonucleaseseIF-2 KinaseEIF2AK3 protein, human

Autor:innen und Institutionen

  • Unidad Universitaria de Investigación, División de Investigación, Facultad de Medicina de la Universidad Nacional Autónoma de México, 04510, Mexico City, Mexico.
  • Unidad de Investigación Traslacional en Biología Celular y Molecular, Hospital Infantil de México Federico Gómez, 06720, Mexico City, Mexico.
  • Unidad de Investigación Epidemiológica en Endocrinología y Nutrición, Hospital Infantil de México Federico Gómez, 06720, Mexico City, Mexico.
  • Unidad de Investigación UNAM-INC, División de Investigación, Facultad de Medicina., Universidad Nacional Autónoma de México, 04510, Mexico City, Mexico.
  • Unidad de Investigación, Departamento de Inmunología, Instituto de Oftalmología "Fundación Conde de Valenciana", 06800, Mexico City, Mexico.
  • Departamento de Bioquímica, Facultad de Medicina. Universidad Nacional Autónoma de México, 04510, Mexico City, Mexico.

Förderung

  • Secretaría de Ciencia, Humanidades, Tecnología e Innovación-Secihti
  • Secretaría de Salud Mexico
  • Hospital Infantil de México Federico Gómez
  • Universidad Nacional Autónoma de México

Zitieren

APA

Román-Anguiano, N. G., Gutiérrez-Muñoz, P. A., Angeles-Floriano, T., Martínez-Rodríguez, N. L., Gutiérrez-Kobeh, L., Jimenez-Martinez, M. C., & Valle-Rios, R. (2026). Cell surface GRP78 and the UPR pathway as novel promising therapeutic targets in cancer: an insight into the treatment of acute leukemia by using GRP78-CART cells. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-026-04413-6

Vancouver

Román-Anguiano NG, Gutiérrez-Muñoz PA, Angeles-Floriano T, Martínez-Rodríguez NL, Gutiérrez-Kobeh L, Jimenez-Martinez MC, et al. Cell surface GRP78 and the UPR pathway as novel promising therapeutic targets in cancer: an insight into the treatment of acute leukemia by using GRP78-CART cells. Clinical and Translational Oncology. 2026. doi:10.1007/s12094-026-04413-6

BibTeX
@article{RomnAnguiano2026,
  author = {Román-Anguiano, Nadia Giovanna and Gutiérrez-Muñoz, Paola Andrea and Angeles-Floriano, Tania and Martínez-Rodríguez, Nancy Lucero and Gutiérrez-Kobeh, Laila and Jimenez-Martinez, Maria C and Valle-Rios, Ricardo},
  title = {Cell surface GRP78 and the UPR pathway as novel promising therapeutic targets in cancer: an insight into the treatment of acute leukemia by using GRP78-CART cells},
  journal = {Clinical and Translational Oncology},
  year = {2026},
  doi = {10.1007/s12094-026-04413-6}
}
Kostenlos starten →